ERVW-1 and malignant colon neoplasm: Since a general aim of a cancer vaccination strategy is to achieve broad targeting of different types of cancer, we used the MelARV Env target protein sequence, originally found in melanoma cells (e.g. B16 cells), to vaccinate against the colon cancer cell line CT26.